Structure-based design and biochemical evaluation of sulfanilamide derivatives as hepatitis B virus capsid assembly inhibitors

References

• Kang H, Yu J, Jung G. Phosphorylation of hepatitis B virus core C-terminally truncated protein (Cp149) by PKC increases capsid assembly and stability. Biochem J 2008;416:47–54.
   PubMed Web of Science ®Google Scholar
• Yokosuka O, Arai M. Molecular biology of hepatitis B virus: Effect of nucleotide substitutions on the clinical features of chronic hepatitis B. Med Mol Morphol 2006;39:113–120.
   PubMed Web of Science ®Google Scholar
• Stray SJ, Zlotnick A. BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly. J Mol Recognit 2006;19:542–548.
   PubMed Web of Science ®Google Scholar
• Zlotnick A, Johnson JM, Wingfield PW, Stahl SJ, Endres D. A theoretical model successfully identifies features of hepatitis B virus capsid assembly. Biochemistry 1999;38:14644–14652.
   PubMed Web of Science ®Google Scholar
• Ceres P, Zlotnick A. Weak protein-protein interactions are sufficient to drive assembly of hepatitis B virus capsids. Biochemistry 2002;41:11525–11531.
   PubMed Web of Science ®Google Scholar
• Singh S, Zlotnick A. Observed hysteresis of virus capsid disassembly is implicit in kinetic models of assembly. J Biol Chem 2003;278:18249–18255.
   PubMed Web of Science ®Google Scholar
• Wingfield PT, Stahl SJ, Williams RW, Steven AC. Hepatitis core antigen produced in Escherichia coli: Subunit composition, conformational analysis, and in vitro capsid assembly. Biochemistry 1995;34:4919–4932.
   PubMed Web of Science ®Google Scholar
• Stray SJ, Ceres P, Zlotnick A. Zinc ions trigger conformational change and oligomerization of hepatitis B virus capsid protein. Biochemistry 2004;43:9989–9998.
   PubMed Web of Science ®Google Scholar
• Leis S, Schneider S, Zacharias M. In silico prediction of binding sites on proteins. Curr Med Chem 2010;17:1550–1562.
   PubMed Web of Science ®Google Scholar
• Zoete V, Grosdidier A, Michielin O. Docking, virtual high throughput screening and in silico fragment-based drug design. J Cell Mol Med 2009;13:238–248.
   PubMed Web of Science ®Google Scholar
• Segall M, Champness E, Obrezanova O, Leeding C. Beyond profiling: Using ADMET models to guide decisions. Chem Biodivers 2009;6:2144–2151.
   PubMed Web of Science ®Google Scholar
• Valerio LG, Yang C, Arvidson KB, Kruhlak NL. A structural feature-based computational approach for toxicology predictions. Expert Opin Drug Metab Toxicol 2010;6:505–518.
   PubMed Web of Science ®Google Scholar
• Wynne SA, Crowther RA, Leslie AG. The crystal structure of the human hepatitis B virus capsid. Mol Cell 1999;3:771–780.
   PubMed Web of Science ®Google Scholar
• Packianathan C, Katen SP, Dann CE 3rd, Zlotnick A. Conformational changes in the hepatitis B virus core protein are consistent with a role for allostery in virus assembly. J Virol 2010;84:1607–1615.
   PubMed Web of Science ®Google Scholar
• Smith JR, Evans KJ, Wright A, Willows RD, Jamie JF, Griffith R. Novel indoleamine 2,3-dioxygenase-1 inhibitors from a multistep in silico screen. Bioorg Med Chem 2012;20:1354–1363.
   PubMed Web of Science ®Google Scholar
• Böhm HJ. LUDI: Rule-based automatic design of new substituents for enzyme inhibitor leads. J Comput Aided Mol Des 1992;6:593–606.
   PubMed Web of Science ®Google Scholar
• Irwin JJ, Shoichet BK. ZINC–a free database of commercially available compounds for virtual screening. J Chem Inf Model 2005;45:177–182.
   PubMed Web of Science ®Google Scholar
• Choi Y, Gyoo Park S, Yoo JH, Jung G. Calcium ions affect the hepatitis B virus core assembly. Virology 2005;332:454–463.
   PubMed Web of Science ®Google Scholar
• Englander JJ, Del Mar C, Li W, Englander SW, Kim JS, Stranz DD et al. Protein structure change studied by hydrogen-deuterium exchange, functional labeling, and mass spectrometry. Proc Natl Acad Sci USA 2003;100:7057–7062.
   PubMed Web of Science ®Google Scholar
• Kang HY, Lee S, Park SG, Yu J, Kim Y, Jung G. Phosphorylation of hepatitis B virus Cp at Ser87 facilitates core assembly. Biochem J 2006;398:311–317.
   PubMed Web of Science ®Google Scholar
• Ganem D. Assembly of hepadnaviral virions and subviral particles. Curr Top Microbiol Immunol 1991;168:61–83.
   PubMed Web of Science ®Google Scholar
• Deres K, Schröder CH, Paessens A, Goldmann S, Hacker HJ, Weber O et al. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science 2003;299:893–896.
   PubMed Web of Science ®Google Scholar
• Zlotnick A, Ceres P, Singh S, Johnson JM. A small molecule inhibits and misdirects assembly of hepatitis B virus capsids. J Virol 2002;76:4848–4854.
   PubMed Web of Science ®Google Scholar
• Stray SJ, Bourne CR, Punna S, Lewis WG, Finn MG, Zlotnick A. A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly. Proc Natl Acad Sci USA 2005;102:8138–8143.
   PubMed Web of Science ®Google Scholar
• Woods VL Jr, Hamuro Y. High resolution, high-throughput amide deuterium exchange-mass spectrometry (DXMS) determination of protein binding site structure and dynamics: Utility in pharmaceutical design. J of Cell Biochem 2011;84:89–98.
   Web of Science ®Google Scholar
• Hoofnagle JH, di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347–356.
   PubMed Web of Science ®Google Scholar